A PHASE 2/3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Clinical Trial Grant
Administered By
Pediatrics, Nephrology
Awarded By
Reata Pharmaceuticals, Inc.
Start Date
January 5, 2018
End Date
December 31, 2020
Administered By
Pediatrics, Nephrology
Awarded By
Reata Pharmaceuticals, Inc.
Start Date
January 5, 2018
End Date
December 31, 2020